Last reviewed · How we verify

NCT07002125

Whole Body Vibration Therapy in Individuals With Type 2 Diabetes

Recruiting now NA Last updated 26 August 2025
What this trial tests

NA trial testing Whole Body Vibration in Type 2 Diabetes in 20 participants. Currently enrolling.

Timeline
1 August 2025
Primary endpoint
1 December 2025
31 December 2025

Quick facts

Lead sponsorAnkara Medipol University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment20
Start date1 August 2025
Primary completion1 December 2025
Estimated completion31 December 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ankara Medipol University

Who can join

18 and older, any sex, with Type 2 Diabetes or Whole Body Vibration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this interventional study is to investigate the effect of whole body vibration therapy on muscle oxygenation, vibration sensation, functional capacity and balance in individuals with Type 2 diabetes. The main questions aimed to be answered are: * Does whole body vibration therapy affect peripheral muscle oxygenation? * Does whole body vibration therapy improve vibration sense, functional capacity and balance compared to aerobic exercise? Participants' muscle oxygenation, vibration sensation, functional capacity and balance parameters will be assessed. They will participate in a whole body vibration therapy or aerobic training program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Whole Body Vibration

Trials testing the same drug.

Other recruiting trials for Type 2 Diabetes

Currently open trials in the same condition.

Other Ankara Medipol University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07002125.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing